Neuroblastoma screening
Campion, P.; Lalonde-Dupuis, D.
Canadian Nurse 87(9): 17-19
1991
ISSN/ISBN: 0008-4581 PMID: 1954611 Document Number: 372477
Document emailed within 1 workday
Related Documents
Sawada, T.; Shikata, T.; Matsumura, T.; Kawakatsu, H.; Sugimoto, T. 1994: Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group Progress in Clinical and Biological Research 385: 371-375Hiyama, E. 2008: Neuroblastoma screening in Japan: population-based cohort study and future aspects of screening Annals of the Academy of Medicine Singapore 37(12 Suppl): 88
Lacour, A.; Chauvin, F.; Duru, G.; Philip, T. 1994: Economic evaluation of screening for neuroblastoma Revue d'Epidemiologie et de Sante Publique 42(1): 24-33
Goodman, S.N. 1991: Neuroblastoma screening data. An epidemiologic analysis American Journal of Diseases of Children 145(12): 1415-1422
Hallett, G.W. 1973: Urine VMA screening for neuroblastoma: is it worth the cost? Pediatrics 51(4): 757
Gershoni-Baruch, R.; Benderly, A. 1989: Mass screening for early detection of neuroblastoma Harefuah 117(7-8): 218-219
Woods, W.G.; Tuchman, M. 1987: Neuroblastoma: the case for screening infants in North America Pediatrics 79(6): 869-873
Schrøder, H.; Møller, J.; Thomsen, A.; Skadborg, R.; Clausen, N. 1991: Screening for neuroblastoma in infants aged 6 months. a method of testing Ugeskrift for Laeger 153(51): 3615-3618
Carlsen, N.L. 1992: Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies Ugeskrift for Laeger 154(52): 3742-3746
Traber, J.; Fischer, K.; Latzin, S.; Hamprecht, B. 1975: Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma times glioma hybrid cells Nature 253(5487): 120-122
Baskin, F.; Carlin, S.C.; Kraus, P.; Friedkin, M.; Rosenberg, R.N. 1975: Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma Molecular Pharmacology 11(1): 105-117
Lauro, G.; Businaro, R.; Butler, R.H.; Revoltella, R. 1980: Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells Journal of the National Cancer Institute 64(5): 1169-1172
Kinoshita, Y.; Yamada, S.; Haraguchi, K.; Takayanagi, T.; Mori, Y.; Takahashi, T.; Haruki, E. 1988: Determination of vanillylmandelic acid, vanillactic acid, and homovanillic acid in dried urine on filter-paper discs by high-performance liquid chromatography with coulometric electrochemical detection for neuroblastoma screening Clinical Chemistry 34(11): 2228-2230
Smith, S. 1995: Screening for diabetic retinopathy. GPs in south London have direct access to screening service Bmj 311(7014): 1229-30; Author Reply 1231
Catalona, W.J. 1997: Screening for prostate cancer. Early screening is important despite lack of data from trials Bmj 315(7101): 187
Bonneux, L.G.A.; Autier, P. 2011: Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality Nederlands Tijdschrift Voor Geneeskunde 155(35): A3774
Levy, H.L.; Madigan, P.M.; Shih, V.E. 1972: Massachusetts metabolic disorders screening program. I. Technics and results of urine screening Pediatrics 49(6): 825-836
Sturner, R.A.; Horton, M.; Funk, S.G.; Barton, J.; Frothingham, T.E.; Cress, J.N. 1982: Adaptations of the Denver Developmental Screening Test: a study of preschool screening Pediatrics 69(3): 346-350
Altarac, S. 2013: Individualized "opportunistic" screening for prostate cancer instead of mass population screening Lijecnicki Vjesnik 135(1-2): 51-52
Gritsman, I.I.; Stranadko, E.F.; Poliudov, L.V. 1987: The Kokonov reaction as a screening test in targeted oncologic screening examinations Laboratornoe Delo 5: 338-340